• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替诺福韦治疗乙型肝炎病毒相关性失代偿期肝硬化导致的致命性乳酸酸中毒:一例报告

Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report.

作者信息

Jung Tae Yang, Jun Dae Won, Lee Kang Nyeong, Lee Hang Lak, Lee Oh Young, Yoon Byung Chul, Choi Ho Soon

机构信息

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.

出版信息

Medicine (Baltimore). 2017 Jun;96(25):e7133. doi: 10.1097/MD.0000000000007133.

DOI:10.1097/MD.0000000000007133
PMID:28640087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5484195/
Abstract

RATIONALE

Recently tenofovir disoproxil fumarate (TDF) has been widely used as a first-line therapy for chronic hepatitis B (CHB) infection. Although TDF demonstrates successful viral suppression, the possibility of renal failure and lactic acidosis has been proposed with TDF administration, especially in human immunodeficiency virus co-infected patients. However, TDF induced lactic acidosis has never been reported in CHB mono-infected patients.

PATIENT CONCERNS

A 59-year-old man received TDF for hepatitis B associated with cirrhosis. After ten days of TDF administration, nausea, vomiting and abdominal pain developed. High anion gap acidosis with elevated lactate level (pH 7.341, pCO2 29.7 mmHg, HCO3- 15.6mmHg, lactate 3.2mmol/L, anion gap 15.4 mEq/L) was developed.

DIAGNOSIS

With no infection, normal diagnostic paracentesis, and urinalysis together with high anion gap and increased blood lactate levels suggested lactic acidosis.

INTERVENTIONS

TDF was stopped, and haemodialysis was performed to control lactic acidosis.

OUTCOMES

Although stopping TDF instantly and treating lactic acidosis using hemodialysis, the patient died.

LESSONS

Although, Fatal lactic acidosis is very rare in TDF patient, however, decompensated cirrhotic patients should be closely observed to keep the possibility of lactic acidosis in mind.

摘要

理论依据

最近,替诺福韦酯(TDF)已被广泛用作慢性乙型肝炎(CHB)感染的一线治疗药物。尽管TDF能成功抑制病毒,但使用TDF时存在肾衰竭和乳酸性酸中毒的可能性,尤其是在合并人类免疫缺陷病毒感染的患者中。然而,在单纯CHB感染患者中从未有过TDF诱发乳酸性酸中毒的报道。

患者情况

一名59岁男性因乙型肝炎合并肝硬化接受TDF治疗。服用TDF十天后,出现恶心、呕吐和腹痛。出现了高阴离子间隙酸中毒,乳酸水平升高(pH 7.341,pCO2 29.7 mmHg,HCO3- 15.6 mmHg,乳酸3.2 mmol/L,阴离子间隙15.4 mEq/L)。

诊断

无感染,诊断性腹腔穿刺和尿液分析正常,同时高阴离子间隙和血乳酸水平升高提示乳酸性酸中毒。

干预措施

停用TDF,并进行血液透析以控制乳酸性酸中毒。

结果

尽管立即停用TDF并使用血液透析治疗乳酸性酸中毒,但患者仍死亡。

经验教训

虽然TDF患者发生致命性乳酸性酸中毒非常罕见,但对于失代偿期肝硬化患者应密切观察,牢记乳酸性酸中毒的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/5484195/fd10542e9382/medi-96-e7133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/5484195/fd10542e9382/medi-96-e7133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/5484195/fd10542e9382/medi-96-e7133-g002.jpg

相似文献

1
Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report.替诺福韦治疗乙型肝炎病毒相关性失代偿期肝硬化导致的致命性乳酸酸中毒:一例报告
Medicine (Baltimore). 2017 Jun;96(25):e7133. doi: 10.1097/MD.0000000000007133.
2
Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.病例报告:替比夫定和替诺福韦治疗慢性乙型肝炎期间发生乳酸酸中毒和横纹肌溶解症。
BMC Gastroenterol. 2018 Apr 6;18(1):45. doi: 10.1186/s12876-018-0773-3.
3
Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis.替诺福韦治疗慢性乙型肝炎相关失代偿期肝硬化的安全性和疗效
World J Gastroenterol. 2017 Apr 7;23(13):2396-2403. doi: 10.3748/wjg.v23.i13.2396.
4
Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report.
J Pharm Pract. 2023 Oct;36(5):1260-1263. doi: 10.1177/08971900221105042. Epub 2022 May 28.
5
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.富马酸替诺福韦二吡呋酯可减少肝硬化慢性乙型肝炎患者的肝细胞癌、肝功能失代偿和死亡。
Aliment Pharmacol Ther. 2019 Nov;50(9):1037-1048. doi: 10.1111/apt.15499. Epub 2019 Sep 16.
6
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance.在有抗病毒耐药性的病毒学抑制的慢性乙型肝炎患者中,从替诺福韦和核苷类似物治疗转换为替诺福韦单药治疗。
J Med Virol. 2018 Mar;90(3):497-502. doi: 10.1002/jmv.24986. Epub 2017 Nov 14.
7
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.乙肝病毒 (HBV) 病毒载量、肝肾功能在接受富马酸替诺福韦二吡呋酯 (TDF) 治疗与未治疗的成年人中的变化:一项回顾性纵向英国队列研究。
BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.
8
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.替诺福韦酯治疗慢性乙型肝炎的有效性和安全性:德国一项为期3年的前瞻性现场实践研究
Dig Dis Sci. 2016 Oct;61(10):3061-3071. doi: 10.1007/s10620-015-3960-x. Epub 2015 Nov 14.
9
Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate.
Pharmacotherapy. 2004 Aug;24(8):1089-94. doi: 10.1592/phco.24.11.1089.36138.
10
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatment.丙型肝炎病毒肝硬化患者乳酸酸中毒与利巴韦林/索非布韦联合治疗。
J Hepatol. 2016 Apr;64(4):790-9. doi: 10.1016/j.jhep.2015.11.034. Epub 2015 Nov 30.

引用本文的文献

1
Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient.拉米夫定、替诺福韦二吡呋酯和考比司他联合治疗 HIV 患者时发生严重乳酸酸中毒。
BMJ Case Rep. 2023 Nov 3;16(11):e255751. doi: 10.1136/bcr-2023-255751.
2
TDF Promotes Glycolysis and Mitochondrial Dysfunction to Accelerate Lactate Accumulation by Downregulating PGC1α in Mice.替诺福韦通过下调小鼠体内的PGC1α促进糖酵解和线粒体功能障碍,加速乳酸积累。
J Clin Transl Hepatol. 2023 Aug 28;11(4):998-1002. doi: 10.14218/JCTH.2022.00082. Epub 2023 Feb 3.
3
Severe Lactic Acidosis Due to Acute Intoxication by Emtricitabine/Tenofovir Alafenamide.

本文引用的文献

1
Lactic acidosis.乳酸性酸中毒
N Engl J Med. 2014 Dec 11;371(24):2309-19. doi: 10.1056/NEJMra1309483.
2
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.核苷和核苷酸类似物在慢性乙型肝炎治疗中的肝外效应
J Gastroenterol Hepatol. 2014 Mar;29(3):428-34. doi: 10.1111/jgh.12499.
3
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.在肝功能受损的慢性乙型肝炎患者中,使用恩替卡韦治疗期间出现严重乳酸酸中毒。
恩曲他滨/替诺福韦艾拉酚胺急性中毒导致的严重乳酸酸中毒
Cureus. 2021 Oct 24;13(10):e19008. doi: 10.7759/cureus.19008. eCollection 2021 Oct.
4
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B.核苷(酸)类似物对慢性乙型肝炎患者的长期疗效和安全性
Ther Adv Infect Dis. 2021 Feb 5;8:2049936120985954. doi: 10.1177/2049936120985954. eCollection 2021 Jan-Dec.
5
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?先进疗法、疫苗接种和精准医学在慢性乙型肝炎病毒感染的治疗和管理中的应用;我们现在在哪里,我们将走向何方?
Viruses. 2020 Sep 7;12(9):998. doi: 10.3390/v12090998.
Hepatology. 2009 Dec;50(6):2001-6. doi: 10.1002/hep.23346.
4
Fatal lactic acidosis associated with tenofovir and abacavir.与替诺福韦和阿巴卡韦相关的致命性乳酸酸中毒。
Int J Infect Dis. 2005 Jul;9(4):228-9. doi: 10.1016/j.ijid.2004.09.010.
5
Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate.
Pharmacotherapy. 2004 Aug;24(8):1089-94. doi: 10.1592/phco.24.11.1089.36138.
6
Drug points: Fatal lactic acidosis associated with tenofovir.用药要点:与替诺福韦相关的致命性乳酸性酸中毒。
BMJ. 2003 Sep 27;327(7417):711. doi: 10.1136/bmj.327.7417.711.
7
Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine.在含去羟肌苷的抗逆转录病毒治疗方案中加用替诺福韦后出现致命性乳酸性酸中毒和急性肾衰竭。
Clin Infect Dis. 2003 Apr 15;36(8):1082-5. doi: 10.1086/368313. Epub 2003 Apr 3.
8
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.替诺福韦处理的人细胞中线粒体毒性的评估:与其他核苷类逆转录酶抑制剂的比较
Antimicrob Agents Chemother. 2002 Mar;46(3):716-23. doi: 10.1128/AAC.46.3.716-723.2002.
9
Fatal hyperkalemia and hyperchloremic acidosis. Association with spironolactone in the absence of renal impairment.
JAMA. 1978 Sep 29;240(14):1516. doi: 10.1001/jama.240.14.1516.
10
Spironolactone-induced hyperchloremic acidosis in cirrhosis.肝硬化患者中螺内酯诱发的高氯性酸中毒
Ann Intern Med. 1979 Mar;90(3):338-40. doi: 10.7326/0003-4819-90-3-338.